Previous 10 | Next 10 |
Image source: The Motley Fool. PRA Health Sciences Inc (NASDAQ: PRAH) Q4 2019 Earnings Call Feb 21, 2020 , 9:00 a.m. ET Operator Continue reading
PRA Health Sciences, Inc. (PRAH) Q4 2019 Earnings Conference Call February 21, 2020, 09:00 ET Company Participants Thomas Byrne - VP, Legal Affairs Colin Shannon - Chairman, CEO & President Michael Bonello - EVP, CFO & Corporate Secretary Conference Call Participants ...
The following slide deck was published by PRA Health Sciences, Inc. in conjunction with their 2019 Q4 earnings Read more ...
PRA Health Sciences (NASDAQ: PRAH ): Q4 Non-GAAP EPS of $1.54 beats by $0.07 ; GAAP EPS of $1.16 misses by $0.04 . More news on: PRA Health Sciences, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Net new business of $658.9 million in the fourth quarter; Net book-to-bill of 1.21 $800.2 million of revenue in the fourth quarter; 9.7% growth at actual foreign exchange rates and 10.2% growth on a constant currency basis Fourth quarter GAAP net income per diluted share of $1.16 a...
RALEIGH, N.C., Feb. 03, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its fourth quarter and year end 2019 results after the market closes on Thursday, February 20, 2020. The Company will also host a conference call on Friday, February 21, 2020 at 9:00 a.m...
Quick Take PPD ( PPD ) has filed to raise $1.5 billion in an IPO of its common stock, per an amended S-1 registration statement . The company provides a wide range of contract research services to biotech and pharmaceutical firms worldwide. PPD is growing revenue at a decelerating rate,...
Aerie Pharmaceuticals (NASDAQ: AERI ) initiated with Neutral rating and $27 (6% upside) price target at Bank of America. More news on: Aurinia Pharmaceuticals Inc., BeyondSpring Inc., Cerecor Inc., Healthcare stocks news, Stocks on the move, , Read more ...
CHANTILLY, Va. , Jan. 7, 2020 /PRNewswire/ -- Perspecta Inc. (NYSE: PRSP), a leading U.S. government services provider, in partnership with PRA Health Sciences (NASDAQ: PRAH), a leading contract research organization (CRO) and health sciences company, today announced the suc...
10x Genomics (NASDAQ: TXG ) initiated with Buy rating and $100 (32% upside) price target at Citigroup. More news on: 10x Genomics, Inc., AbbVie Inc., AdaptHealth Corp., Healthcare stocks news, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
PRA Health Sciences Inc. Company Name:
PRAH Stock Symbol:
NASDAQ Market:
PRA Health Sciences Inc. Website:
DT Midstream Set to Join S&P MidCap 400 DT Midstream Set to Join S&P MidCap 400 PR Newswire NEW YORK , June 28, 2021 /PRNewswire/ -- DT Midstream Inc. (NYSE: DTM) will replace PRA Health Sciences Inc. (NASD: PRAH) in the S&P MidCap 400 effective p...
Through this strategic partnership, the network aims to reach more than 25,000 physicians and 40 million patients, accelerating trial recruitment and enrollment efforts and expanding patients’ access to clinical research Veradigm®, a leading provider of healthcar...
Strengthening Board of Directors with Expertise in Innovative Product Launches NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiat...